Stage II Renal Pelvis Cancer AJCC v7
1 clinical trials · Condition
◉ Watch Stage II Renal Pelvis Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
Track Stage II Renal Pelvis Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.